FDA-Inspected Site

Nordmark Pharma GmbH

9 FDA inspections are on record for Nordmark Pharma GmbH in Uetersen, Germany.

483· Form 483 issued

Uetersen, Germany · Last updated July 10, 2026

Overview

  • 9 FDA inspections are on record.
  • 7 inspections produced a Form 483.
  • The most recent recorded inspection date is 2025-02-13.

At a glance

Inspections

9

Form 483s

7

EIRs

0

Last outcome

Form 483

Inspection history

FDA inspections on record, most recent first.

InspectionCategoryOutcomeForm 483
6 Feb 2025 – 13 Feb 2025Human Drugs483On file
29 Aug 2023 – 31 Aug 2023Human DrugsClean
12 Aug 2019 – 16 Aug 2019Human Drugs483On file
13 Feb 2017 – 17 Feb 2017Human Drugs483On file
17 Nov 2014 – 20 Nov 2014Human Drugs483On file
29 Nov 2012Not recorded483On file
26 Feb 2010Not recordedClean
9 Apr 2009Not recorded483On file
19 Jun 2008Not recorded483On file

Observations on record

Form 483 observations cited at this site, most recent first.

20 Nov 2014
21 CFR 211.194(b)

Test method modification records not maintained

Cited by Timothy T Kapsala

Investigators

FDA investigators tied to this site in the record.

MRA MunizN1 insp.
Charles L Zhou1 insp.
Lucila B Nwatu1 insp.
Timothy T Kapsala1 insp.
Michele L Obert1 insp.
Yumi J Hiramine1 insp.
Gwyn G Dickinson1 insp.
Felix Maldonado1 insp.
Paraluman S Leonin1 insp.

Recurring citations

CFR citation patterns observed across this site's inspections.

CitationWhat it coversCited
21 CFR 211.194(b)Cited across public-safe Form 483 observations1x

Full site report

Get the verbatim findings behind Nordmark Pharma GmbH's 7 Form 483s

Verbatim observations and recurring CFR citations, so your team knows what this site gets cited for.

  • The site's full inspection history, with every Form 483 and its outcome
  • Warning letters and recalls tied to the company behind it
  • Whether recurring CFR citations get closed out or repeat

Related sites